Sugar water shot may ease stroke shoulder pain
NCT ID NCT06988228
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether injecting a 15% dextrose (sugar water) solution into the shoulder could reduce pain and improve movement in stroke survivors with hemiplegic shoulder pain. Forty participants received either dextrose injections or a placebo (salt water) over three sessions, plus exercise therapy. The main goal was to measure pain changes at rest, after exercise, and during daily activities up to three months later.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 15% dextrose solution
- What this could lead to
- If it works, this could offer a simple, low-cost injection to ease shoulder pain and improve mobility after a stroke.
- What could go wrong
- This is a small, completed trial with only 40 participants, so results may not apply to everyone. The placebo group also received exercise therapy, making it hard to know how much the dextrose alone helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Sep 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients aged between 40 and 75 years History of stroke Brunnstrom stage 2 or higher in the upper extremity Provided written informed consent and agreed to participate in the study Exclusion Criteria: History of any prior injection therapy to the shoulder region Previous radiotherapy or surgery involving the shoulder Pre-stroke shoulder pain History of shoulder surgery History of inflammatory joint disease Presence of neuromuscular disorders Full-thickness rotator cuff tear Patients with aphasia or severe cognitive impairment Presence of pectoral muscle spasticity Active malignancy with acute inflammation at the treatment site Known coagulation disorder with INR ≥ 4 Presence of vascular conditions such as deep vein thrombosis, phlebitis, varicose veins, or arterial disease in the affected limb
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hemiplegic shoulder pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul Physical Medicine and Rehabilitation Training and Research Hospital
Istanbul, bahçelievler, 34186, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Robot could let stroke patients rehab their hands at home without a therapist
- Moving patterns may help stroke survivors read faster
- Vibrating wearables put stroke walking to the test
- Robot plus electrical stimulation aims to rebuild arm movement after stroke
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next